These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33302374)

  • 1. Deleterious Effects of Hyperactivity of the Renin-Angiotensin System and Hypertension on the Course of Chemotherapy-Induced Heart Failure after Doxorubicin Administration: A Study in Ren-2 Transgenic Rat.
    Kala P; Bartušková H; Piťha J; Vaňourková Z; Kikerlová S; Jíchová Š; Melenovský V; Hošková L; Veselka J; Kompanowska-Jezierska E; Sadowski J; Gawrys O; Maxová H; Červenka L
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and
    Jíchová Š; Gawryś O; Kompanowska-Jezierska E; Sadowski J; Melenovský V; Hošková L; Červenka L; Kala P; Veselka J; Čertíková Chábová V
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
    Opocenský M; Dvorák P; Malý J; Kramer HJ; Bäcker A; Kopkan L; Vernerová Z; Tesar V; Zima T; Bader M; Ganten D; Janda J; Vanecková I
    Physiol Res; 2004; 53(6):581-93. PubMed ID: 15588125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Červenka L; Bíbová J; Husková Z; Vaňourková Z; Kramer HJ; Herget J; Jíchová Š; Sadowski J; Hampl V
    Physiol Res; 2015; 64(1):11-24. PubMed ID: 25194129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilatory responses of renal interlobular arteries to epoxyeicosatrienoic acids analog are not enhanced in Ren-2 transgenic hypertensive rats: evidence against a role of direct vascular effects of epoxyeicosatrienoic acids in progression of experimental heart failure.
    Sporková A; Husková Z; Škaroupková P; Rami Reddy N; Falck JR; Sadowski J; Červenka L
    Physiol Res; 2017 Mar; 66(1):29-39. PubMed ID: 27782740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms.
    Rahimi O; Kirby J; Varagic J; Westwood B; Tallant EA; Gallagher PE
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H883-H894. PubMed ID: 32083974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats.
    Vanecková I; Skaroupková P; Dvorák P; Certíková Chábová V; Tesar V; Bader M; Ganten D; Kramer HJ
    Physiol Res; 2005; 54(1):17-24. PubMed ID: 15717837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
    Husková Z; Kramer HJ; Vanourková Z; Cervenka L
    J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
    Chábová VC; Kramer HJ; Vanecková I; Vernerová Z; Eis V; Tesar V; Skaroupková P; Thumová M; Schejbalová S; Husková Z; Vanourková Z; Kolský A; Imig JD; Cervenka L
    Vascul Pharmacol; 2007; 47(2-3):145-59. PubMed ID: 17604232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive
    Hrdlička J; Neckář J; Papoušek F; Husková Z; Kikerlová S; Vaňourková Z; Vernerová Z; Akat F; Vašinová J; Hammock BD; Hwang SH; Imig JD; Falck JR; Červenka L; Kolář F
    Front Pharmacol; 2019; 10():159. PubMed ID: 30881303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats.
    Mitchell KD; Jacinto SM; Mullins JJ
    Am J Physiol; 1997 Aug; 273(2 Pt 2):F246-53. PubMed ID: 9277585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
    Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.
    Kopkan L; Husková Z; Vanourková Z; Thumová M; Skaroupková P; Malý J; Kramer HJ; Dvorák P; Cervenka L
    Vascul Pharmacol; 2009; 51(2-3):175-81. PubMed ID: 19539780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-linked differences in the course of chronic kidney disease and congestive heart failure: a study in 5/6 nephrectomized Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula.
    Červenka L; Škaroupková P; Kompanowska-Jezierska E; Sadowski J
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):883-95. PubMed ID: 27385471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats.
    Jacinto SM; Mullins JJ; Mitchell KD
    Am J Physiol; 1999 Feb; 276(2):F315-22. PubMed ID: 9950963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
    Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
    Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Dvorák P; Kramer HJ; Bäcker A; Malý J; Kopkan L; Vanecková I; Vernerová Z; Opocenský M; Tesar V; Bader M; Ganten D; Janda J; Cervenka L
    Kidney Blood Press Res; 2004; 27(4):248-58. PubMed ID: 15286437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.
    Husková Z; Kramer H; Vanourková Z; Thumová M; Malý J; Opocenský M; Skaroupková P; Kolský A; Vernerová Z; Cervenka L
    Kidney Blood Press Res; 2007; 30(1):45-55. PubMed ID: 17259738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.